Comerica Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Sell |
15,869
-557
| -3% | -$70.5K | 0.01% | 1128 |
|
2025
Q1 | $2.1M | Sell |
16,426
-1,303
| -7% | -$167K | 0.01% | 1078 |
|
2024
Q4 | $2.34M | Buy |
17,729
+226
| +1% | +$29.9K | 0.01% | 1058 |
|
2024
Q3 | $2.55M | Sell |
17,503
-651
| -4% | -$94.8K | 0.01% | 1031 |
|
2024
Q2 | $2.49M | Sell |
18,154
-475
| -3% | -$65.2K | 0.01% | 1022 |
|
2024
Q1 | $2.56M | Buy |
18,629
+1,169
| +7% | +$160K | 0.01% | 1060 |
|
2023
Q4 | $2.37M | Sell |
17,460
-1,606
| -8% | -$218K | 0.01% | 1076 |
|
2023
Q3 | $2.33M | Buy |
+19,066
| New | +$2.33M | 0.01% | 1001 |
|
2022
Q2 | – | Sell |
-1,646
| Closed | -$212K | – | 2166 |
|
2022
Q1 | $212K | Hold |
1,646
| – | – | ﹤0.01% | 2085 |
|
2021
Q4 | $210K | Buy |
1,646
+333
| +25% | +$42.5K | ﹤0.01% | 2079 |
|
2021
Q3 | $208K | Sell |
1,313
-29
| -2% | -$4.59K | ﹤0.01% | 2137 |
|
2021
Q2 | $221K | Sell |
1,342
-71
| -5% | -$11.7K | ﹤0.01% | 2230 |
|
2021
Q1 | $219K | Buy |
1,413
+19
| +1% | +$2.95K | ﹤0.01% | 2231 |
|
2020
Q4 | $230K | Buy |
+1,394
| New | +$230K | ﹤0.01% | 2210 |
|
2020
Q2 | – | Sell |
-2,459
| Closed | -$310K | – | 2282 |
|
2020
Q1 | $310K | Buy |
+2,459
| New | +$310K | ﹤0.01% | 1940 |
|
2019
Q2 | – | Sell |
-8,047
| Closed | -$916K | – | 2301 |
|
2019
Q1 | $916K | Buy |
+8,047
| New | +$916K | 0.01% | 1624 |
|
2018
Q3 | – | Sell |
-1,833
| Closed | -$217K | – | 2286 |
|
2018
Q2 | $217K | Sell |
1,833
-268
| -13% | -$31.7K | ﹤0.01% | 2176 |
|
2018
Q1 | $222K | Sell |
2,101
-1
| -0% | -$106 | ﹤0.01% | 2154 |
|
2017
Q4 | $244K | Buy |
+2,102
| New | +$244K | ﹤0.01% | 2141 |
|
2016
Q1 | – | Sell |
-2,802
| Closed | -$282K | – | 2095 |
|
2015
Q4 | $282K | Buy |
+2,802
| New | +$282K | ﹤0.01% | 1886 |
|
2013
Q4 | – | Sell |
-17,877
| Closed | -$1.25M | – | 2375 |
|
2013
Q3 | $1.25M | Sell |
17,877
-546
| -3% | -$38.1K | 0.01% | 1487 |
|
2013
Q2 | $1.07M | Buy |
+18,423
| New | +$1.07M | 0.01% | 1358 |
|